Clinical trial
MK0954A-264 Filter Study (0954A-264)(COMPLETED)
NCT00307060 · Organon and Co, Industry · Completed
Key facts
| NCT number | NCT00307060 |
|---|---|
| Title | MK0954A-264 Filter Study (0954A-264)(COMPLETED) |
| Official title | A Randomized, Double-Blind, Parallel-Filter Study to Evaluate the Antihypertensive Efficacy and Safety of Losartan-HCTZ Combination as Compared to Losartan Monotherapy in Patients With Essential Hypertension |
| Lead sponsor | Organon and Co, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Mild to Severe Hypertension |
| Intervention type | Drug |
| Interventions | MK0954A, hydrochlorothiazide (+) losartan potassium / Duration of Treatment: 6 weeks, losartan / Duration of Treatment: 6 weeks |
| Enrollment | 274 |
| Start date | Dec 1, 2004 |
| Primary completion | Jun 1, 2005 |
| Completion | Jun 2, 2005 |
| First posted | Mar 27, 2006 |
| Last update posted | Aug 15, 2024 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: